research use only

Amfebutamone (Bupropion) HCl AChR inhibitor

Cat.No.S2452

Amfebutamone (Bupropion) HCl(Wellbutrin) is a selective norepinephrine-dopamine reuptake inhibitor with IC50 of 6.5 and 3.4 μM for the reuptake of dopamine and norepinephrine, respectively.
Amfebutamone (Bupropion) HCl AChR inhibitor Chemical Structure

Chemical Structure

Molecular Weight: 276.2

Quality Control

Chemical Information, Storage & Stability

Molecular Weight 276.2 Formula

C13H18ClNO.HCl

Storage (From the date of receipt)
CAS No. 31677-93-7 Download SDF Storage of Stock Solutions

Synonyms Wellbutrin Smiles CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C.Cl

Solubility

In vitro
Batch:

DMSO : 8 mg/mL (28.96 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : Insoluble

Ethanol : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Targets/IC50/Ki
Dopamine receptor [1]
AChR [1]
References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT04902625 Recruiting
Obesity Morbid|Bariatric Surgery Candidate|Medication Persistence
Zuyderland Medisch Centrum|Nederlandse Obesitas Kliniek
March 21 2023 Phase 4
NCT04718740 Completed
Recurrent Ovarian Cancer
Jiangsu HengRui Medicine Co. Ltd.
June 25 2021 Phase 1

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.

Signaling Pathway Map